Hypoglycemic Coma in a Hemodialysis Patient Receiving Blood Glucose-Lowering Therapy With the Single Agent Teneligliptin

Blood glucose management in patients undergoing dialysis is clinically challenging. In this population, most conventional oral hypoglycemic agents are contraindicated, especially from the perspective of pharmacokinetics. Dipeptidyl peptidase-4 inhibitors exert unique pharmacologic actions via glucos...

Descripción completa

Detalles Bibliográficos
Autores principales: Minezumi, Takumi, Takeda, Shin-ichi, Igarashi, Yusuke, Sato, Kentaro, Murakami, Yoshiaki, Nagata, Daisuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5863859/
https://www.ncbi.nlm.nih.gov/pubmed/29581705
http://dx.doi.org/10.1177/1179547618763358

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5863859/
https://www.ncbi.nlm.nih.gov/pubmed/29581705
http://dx.doi.org/10.1177/1179547618763358

Ejemplares similares